Acute pyelonephritis is a bacterial infection of the kidneys that affects up to 2 percent of pregnant women. In most cases, the infection first develops in the lower urinary tract. If it’s not ...

I often find myself under- or overestimating the incidence of certain nephrology-related conditions. I know this "error" is, in part, due to an "exposure bias" in my practice. I tend to overestimate ...

It has been difficult to devise a practical clinical approach to reliably separate simple urinary tract infections (UTIs) from UTIs that also involve the kidneys (acute pyelonephritis). The gold ...

Acute pyelonephritis is a bacterial infection that causes inflammation in the kidneys. This is an unexpected and serious kidney infection in which the urinary tract infection travels from the bladder ...

An expert briefly describes the study “Evaluation of Clinical Efficacy of Systemic Antibiotics for Treatment of Acute Pyelonephritis in Adults: A Network Meta-Analysis of Randomized Controlled Trials, ...

"The five factors with the highest odds of developing APN included obstructive and reflux uropathy, presentation to an acute care facility, urinary retention, history of UTI, and renal comorbidities.

Background A 54-year-old nondiabetic male presented with high fever, vague lower abdominal pain and leakage of urine around his long-standing suprapubic catheter. Examination revealed pyrexia and ...

Acute pyelonephritis is a disease that occurs due to severe kidney infection. The infection starts through the lower urinary tract infection (UTI) and spreads through the urethra, where the bacteria ...

To determine the frequency and clinical significance of ultrasonographically detectable alterations in renal volume and anatomy that are associated with acute pyelonephritis, 25 women underwent renal ...

During the years 1932 to 1945, post-mortem examination disclosed 26 cases of this lesion at the Mallory Institute of Pathology, Boston City Hospital, and at the Peter Bent Brigham Hospital, 19 of ...

RARITAN, N.J., Sept. 17Â -- The U.S. Food and Drug Administration (FDA) has approved use of the five-day, once-daily regimen of LEVAQUIN(R) (levofloxacin) 750 mg I.V. and oral, for the treatment of ...